95 related articles for article (PubMed ID: 11297583)
1. Prostate-specific antigen and human glandular kallikrein 2 are markedly elevated in urine of patients with polycystic ovary syndrome.
Obiezu CV; Scorilas A; Magklara A; Thornton MH; Wang CY; Stanczyk FZ; Diamandis EP
J Clin Endocrinol Metab; 2001 Apr; 86(4):1558-61. PubMed ID: 11297583
[TBL] [Abstract][Full Text] [Related]
2. Is prostate-specific antigen a potential new marker of androgen excess in polycystic ovary syndrome?
Vural B; Ozkan S; Bodur H
J Obstet Gynaecol Res; 2007 Apr; 33(2):166-73. PubMed ID: 17441890
[TBL] [Abstract][Full Text] [Related]
3. Serum and urinary prostate-specific antigen and urinary human glandular kallikrein concentrations are significantly increased after testosterone administration in female-to-male transsexuals.
Obiezu CV; Giltay EJ; Magklara A; Scorilas A; Gooren LJ; Yu H; Howarth DJ; Diamandis EP
Clin Chem; 2000 Jun; 46(6 Pt 1):859-62. PubMed ID: 10839777
[TBL] [Abstract][Full Text] [Related]
4. Molecular forms of prostate-specific antigen and human kallikrein 2 (hK2) in urine are not clinically useful for early detection and staging of prostate cancer.
Pannek J; Rittenhouse HG; Evans CL; Finlay JA; Bruzek DJ; Cox JL; Chan DW; Subong EN; Partin AW
Urology; 1997 Nov; 50(5):715-21. PubMed ID: 9372881
[TBL] [Abstract][Full Text] [Related]
5. The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinoma.
Recker F; Kwiatkowski MK; Piironen T; Pettersson K; Lümmen G; Wernli M; Wiefelspütz J; Graber SF; Goepel M; Huber A; Tscholl R
Cancer; 1998 Dec; 83(12):2540-7. PubMed ID: 9874461
[TBL] [Abstract][Full Text] [Related]
6. Similar rates of exponential decrease in serum concentrations of free prostate-specific antigen (PSA), PSA complexed to alpha-1-antichymotrypsin, and human glandular kallikrein 2 (hK2) in prostate cancer patients treated with GnRH-analogues.
Björk T; Schalken J; Wittjes W; Ljungberg B; Lilja H
Prostate; 2001 Apr; 47(1):14-20. PubMed ID: 11304725
[TBL] [Abstract][Full Text] [Related]
7. Prostate-specific antigen in female serum, a potential new marker of androgen excess.
Melegos DN; Yu H; Ashok M; Wang C; Stanczyk F; Diamandis EP
J Clin Endocrinol Metab; 1997 Mar; 82(3):777-80. PubMed ID: 9062481
[TBL] [Abstract][Full Text] [Related]
8. Dramatic suppression of plasma and urinary prostate specific antigen and human glandular kallikrein by antiandrogens in male-to-female transsexuals.
Obiezu CV; Giltay EJ; Magklara A; Scorilas A; Gooren L; Yu H; Diamandis EP
J Urol; 2000 Mar; 163(3):802-5. PubMed ID: 10687981
[TBL] [Abstract][Full Text] [Related]
9. Serum human glandular kallikrein-2 protease levels predict the presence of prostate cancer among men with elevated prostate-specific antigen.
Nam RK; Diamandis EP; Toi A; Trachtenberg J; Magklara A; Scorilas A; Papnastasiou PA; Jewett MA; Narod SA
J Clin Oncol; 2000 Mar; 18(5):1036-42. PubMed ID: 10694554
[TBL] [Abstract][Full Text] [Related]
10. Measurement of prostate-specific antigen and human glandular kallikrein 2 in different body fluids.
Lövgren J; Valtonen-André C; Marsal K; Lilja H; Lundwall A
J Androl; 1999; 20(3):348-55. PubMed ID: 10386814
[TBL] [Abstract][Full Text] [Related]
11. Discrimination of men with prostate cancer from those with benign disease by measurements of human glandular kallikrein 2 (HK2) in serum.
Becker C; Piironen T; Pettersson K; Björk T; Wojno KJ; Oesterling JE; Lilja H
J Urol; 2000 Jan; 163(1):311-6. PubMed ID: 10604382
[TBL] [Abstract][Full Text] [Related]
12. Prostate specific antigen (PSA) in diagnosis of polycystic ovarian syndrome - a new insight.
Rudnicka E; Radowicki S; Suchta K
Gynecol Endocrinol; 2016 Nov; 32(11):931-935. PubMed ID: 27426018
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of 3alpha-androstanediol glucuronide in young women with polycystic ovary syndrome, idiopathic hirsutism and in normal subjects.
Meczekalski B; Slopien R; Warenik-Szymankiewicz A
Eur J Obstet Gynecol Reprod Biol; 2007 May; 132(1):88-92. PubMed ID: 16979812
[TBL] [Abstract][Full Text] [Related]
14. Antiandrogen drugs lower serum prostate-specific antigen (PSA) levels in hirsute subjects: evidence that serum PSA is a marker of androgen action in women.
Negri C; Tosi F; Dorizzi R; Fortunato A; Spiazzi GG; Muggeo M; Castello R; Moghetti P
J Clin Endocrinol Metab; 2000 Jan; 85(1):81-4. PubMed ID: 10634368
[TBL] [Abstract][Full Text] [Related]
15. Comparison of prostate-specific antigen and hormone levels among men in Singapore and the United States.
Cheng I; Yu MC; Koh WP; Pike MC; Kolonel LN; Henderson BE; Stram DO
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1692-6. PubMed ID: 16030103
[TBL] [Abstract][Full Text] [Related]
16. Expression of a prostate-associated protein, human glandular kallikrein (hK2), in breast tumours and in normal breast secretions.
Black MH; Magklara A; Obiezu C; Levesque MA; Sutherland DJ; Tindall DJ; Young CY; Sauter ER; Diamandis EP
Br J Cancer; 2000 Jan; 82(2):361-7. PubMed ID: 10646889
[TBL] [Abstract][Full Text] [Related]
17. Expression of human prostate-specific glandular kallikrein protein (hK2) in the breast cancer cell line T47-D.
Hsieh ML; Charlesworth MC; Goodmanson M; Zhang S; Seay T; Klee GG; Tindall DJ; Young CY
Cancer Res; 1997 Jul; 57(13):2651-6. PubMed ID: 9205072
[TBL] [Abstract][Full Text] [Related]
18. Structural comparison of prostate-specific antigen and human glandular kallikrein using molecular modeling.
Bridon DP; Dowell BL
Urology; 1995 May; 45(5):801-6. PubMed ID: 7538242
[TBL] [Abstract][Full Text] [Related]
19. Evidence for the importance of peripheral tissue events in the development of hirsutism in polycystic ovary syndrome.
Lobo RA; Goebelsmann U; Horton R
J Clin Endocrinol Metab; 1983 Aug; 57(2):393-7. PubMed ID: 6223045
[TBL] [Abstract][Full Text] [Related]
20. Serum human glandular kallikrein (hK2) and insulin-like growth factor 1 (IGF-1) improve the discrimination between prostate cancer and benign prostatic hyperplasia in combination with total and %free PSA.
Scorilas A; Plebani M; Mazza S; Basso D; Soosaipillai AR; Katsaros N; Pagano F; Diamandis EP
Prostate; 2003 Feb; 54(3):220-9. PubMed ID: 12518327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
